1/33
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
examples of biochemical assay
saturation
competition
scintillation proximity
GPCR
What piece of equipment is commonly used in assays to optimise efficiency?
microplates with isolated enzymes and membrane fragments
more assays can be done simultaneously with multiwell pipettes or robot automation
improved efficiency and reduced costs
Outline the principles of radioligand binding assay used to screen compounds and explain how IC50 and Ki for drug binding can be determined from the results. (10 marks)
tissue sample with target protein is homogenised
incubation 1 - sample is incubated with single concentration of radioactive labelled ligand and is washed to filter
radioactivity is measured by counter
incubation 2 - excess cold unlabelled ligand (drug) at increasing conc is added to the sample and radioligand and washed to be measured again
specific binding = incubation 1 - incubation 2
radioactviity is plotted against ligand concentration concentration for each drug
IC50 is conc of drug which inhibits 50% of radioligand binding
Ki derived from cheng presoff equation
ligand binding assay
ability of a ligand to bind to a target
first type of assay used in search of compounds that interact with a target
Advantages of radioligand binding assays, and what radiolabels are used?
simple, easy automated for high input
tritium, iodine-125 are most common, sulfur has more specific usage
requirements for radioligand binding assay
tissue containing target protein
radiolabelled ligand
instrument to detect and measure radioactivity
method to separate bound ligand from free ligand
separation of specific binding from non specific
incubation 1 - radioligand and tissues
incubation 2 - radioligand, tissue and excess unlabelled (cold) ligand
bound radioactivity = non specific binding
radioligand at low conc cannot compete with excess cold ligand for receptor
non specific binding not displaced as not saturable
specific binding = incubation 1 - incubation 2
displacement assays
critical part of drug screening
a single concentration of radioligand used, usually below Kd
specific binding determined by adding competing ligands at a range of concentrations
evaluate potency of displacing radioligand
What does competition curve measure and advantage?
IC50
non specific binding is seen more clearly - plateau not at zero
key advantage of scintillation proximity assay
developed to avoid the need to separate bound ligand from the free ligand
scintillation proximity assay characteristics
does not use homogenous sample of the tissue
membrane containing receptor is attached to microbead containing scintillant
radioligand in proximity of bead evokes light emission
beta particle is released
What do binding assays not usually measure? What is the exception?
bind assays do not measure efficacy
except GTPyS assay
gives functional information, measures activity of ligand to bind to its specific receptor
GPCR activation and GTPyS assay
GTP gamma s binds to GPCR instead of GTP
no hydrolysis, permanent activation
sulfur is radioactive and acts as a marker for agonist binding to receptor, and receptor activation
how do antagonists differentiate from agonists in GTPyS assays
prevent incorporation of GTP gamma s into g protein
no activation, no radioligand activity will be measured
miniaturisation of assays
multiwell plates
more wells, less reaction volume
allows optomisation but compromises reproducibility and accuracy
What are the applications of a bioassay (4 marks)
identification of unknown substance
quantification of concentration of a substance
determine potency
study physiological and pharmacological function
identification of unknown substance with bioassays
known agents must have unique effects which are well defined
eg insulin to promote glucose absorption, adrenaline to increase heart rate
bioassays need to be specific and sensitive - respond to low conc of unknown substance
NO identification with bioassay
bioassay identifies NO as the EDRF
assay tissue relaxed when NO applied anywhere
ACh applied to donor tissue or endothelial cells
did not relax when ACh was applied directly to assay tissue
Which active substances cannot be measured by chemical means?
clotting factors, immunoglobins, peptides, cytokines, growth factors, vaccines and monoclonal antibodies
quantified by reproducible biological effect
quantification of concentration with bioassay example
doses of insulin are defines as international units , measured against a standard sample
why can same weight of insulin in different batches have different potencies?
phosphorylation, glycosylation, post translational modifications etc
lead to changes in molecular weights
determination of potency
potency and efficacy can only be tested using bioassays
response at each conc plotted as function of log[X]
EC50 - conc to give 50% of max response
potency - pD2 - log 10 of molar EC50 conc
How are bioassay measurements conducted? For each state whether it a quantal or graded response. (4 marks)
groups of animals - quantal behavioural
individuals or humans - graded response
organ or tissues - graded response
cell cultures - graded response
graded response examples
contraction of smooth muscle to ACh
fall in blood glucose in response to insulin
pain relief
quantal response examples
% of animals given a drug that develops seizures
% of people showing adverse reaction to a new drug
% of population with COVID-19 symptoms
How drug potency is measured for quantal vs graded?
graded - EC50
quantal - ED50
relative potency
complete dose response curve may not be necessary to compare potency of two drugs acting at the same receptor
concentration below and above EC50 are applied, EC50 can be esitmated for each drug and relative potency can be determined
What 5 properties determine a good bioassay?
sensitivity
specificity
precision
accuracy
efficiency
how is precision seen in bioassay
concentration response curve will have a steep slope
response is apparent over a narrow range of conc, small increment in conc produces a large increase in response
Advantage of bioassays
measures biological activity
Disadvantages of bioassays
less sensitive
more variable
slower
more limited in the number of samples that can be tested
use of assays during drug development and discovery
target validation - confirmation of biological activity of the target
requires in vitro and in vivo bioassays
genetically modified tissues and animals
Define biochemical assays and give 2 examples (2 marks)
analytical methods used to measure the concentration, activity, or interactions of biological molecules (e.g., enzymes, proteins, DNA, and metabolites)
binding assays and reporter gene assays